Products
Maprocin
Generic
Name
Ciprofloxacin Hydrochloride
Preparation
Maprocin 500 mg tablet: Each tablet contains 500 mg Ciprofloxacin as Ciprofloxacin Hydrochloride USP.
Maprocin 750 mg tablet: Each tablet contains 750 mg Ciprofloxacin as Ciprofloxacin Hydrochloride USP.
Maprocin suspension: After reconstitution each 5 ml suspension contains 250 mg Ciprofloxacin as Ciprofloxacin Hydrochloride USP.
Maprocin 750 mg tablet: Each tablet contains 750 mg Ciprofloxacin as Ciprofloxacin Hydrochloride USP.
Maprocin suspension: After reconstitution each 5 ml suspension contains 250 mg Ciprofloxacin as Ciprofloxacin Hydrochloride USP.
Therapeutic
Class
Antibiotic
Indications
Typhoid fever, urinary tract infections, respiratory tract infections, gastro-intestinal tract infections, uro-genital tract infections, bone & joint infections, skin & skin structure infections, gonorrhea and other sexually transmitted diseases, severe systemic infections, surgical prophylaxis.
Dosage & Administration
Recommended dose is 250 - 750 mg (5 ml to 15 ml) twice daily.
Urinary Tract Infections
Acute uncomplicated - 250 mg 12 hrly - 3 Days
Mild / Moderate - 250 mg 12 hrly - 7-14 Days
Severe / Complicated - 500 mg 12 hrly - 7-14 Days
Chronic Bacterial Prostatitis
Mild / Moderate - 500 mg 12 hrly - 28 Days
Lower respiratory tract infection
Mild / Moderate - 500 mg 12 hrly - 7-14 Days
Severe / Complicated - 750 mg 12 hrly - 7-14 Days
Typhoid Fever
Mild / Moderate - 500 mg 12 hrly - 10 Days
Infectious diarrhea
Mild / Moderate / Severe - 500 mg 12 hrly - 5-7 Days
Bone & joint infection
Mild / Moderate - 500 mg 12 hrly - 4-6 Weeks
Severe / Complicated - 750 mg 12 hrly - 4-6 Weeks
Skin & skin structure infections
Mild / Moderate - 500 mg 12 hrly - 7-14 Days
Severe / Complicated - 750 mg 12 hrly - 7-14 Days
Urethral and cervical gonococcal infections
Uncomplicated - 250 mg Single dose - Single dose
Contraindications
Maprocin is contraindicated in patients who have shown hypersensitivity to Ciprofloxacin and other quinolones. Maprocin is also contraindicated in pregnant women and nursing mothers, except where the benefits of the treatment exceed the risk.